Noticias y Actividades de Mirum Pharmaceuticals

Mirum Pharmaceuticals es una de las ...

• Russell 3000;
• TOB Iconic 10,000.

Mirum Pharmaceuticals es una empresa que cotiza bajo el símbolo de cotización MIRM (US).

Ver el organigrama con sus 20 ejecutivos principales

Biografías más buscadas en Mirum Pharmaceuticals

• Chris Peetz, Director, President and Chief Executive Officer
• William Fairey, Director
• Mike Grey, Executive Chairman of the Board

Crear su alerta
para seguir los movimientos de los ejecutivos en Mirum Pharmaceuticals.

Mirum Pharmaceuticals tiene 1.835 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Eli Lilly (Estados Unidos).

Popular M&A news in Farmacia

• Imbria Pharmaceuticals acaba de anunciar una recaudación de fondos de 58 millones de dólares. (publicado el 10 de abril de 2025).
• Clario ha NRx Pharmaceuticals adquirido (publicado el 18 de marzo de 2025).
• Knight Therapeutics has announced the acquisition of Paladin Labs  (publicado el 12 de marzo de 2025).

Otros contactos sugeridos en el sector Farmacia

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets en Bristol-Myers Squibb
• Kristin Berkinsky - Chief Human Resources Officer en Adare Pharmaceuticals
• Seth Harrison - Chairman and Director en Braeburn Pharmaceuticals

Saber más sobre el sector Farmacia

Últimos comunicados de prensa de Mirum Pharmaceuticals

• Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates
• Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Mirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
• Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
• Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD’s The Liver Meeting
• Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
• Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
• Mirum Pharmaceuticals to Showcase LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual Meeting
• View more press releases Close

Redes sociales sobre Mirum Pharmaceuticals

• Mirum Pharmaceuticals en Wikipedia, Google News y Yahoo Finance
• Mirum Pharmaceuticals en LinkedIn, Twitter y YouTube